Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 1,556

The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.

Methicillin-resistant Staphylococcus aureus

Open access
Lee, Andie S., de Lencastre, Hermínia, Garau, Javier, Kluytmans, Jan, Malhotra-Kumar, Surbhi, Peschel, Andreas, Harbarth, Stephan · 2018 · Nature Reviews Disease Primers

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrdp.2018.33

Cites

220 of 220 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Items 201–220 of 220

Research works printed but not linked: 31

  1. Faoagali, J. L., Thong, M. L. & Grant, D. Ten years’ experience with methicillin-resistant Staphylococcus aureus in a large Australian hospital. J. Hosp. Infect. 20, 113–119 (1992). · doi:10.1016/0195-6701(92)90113-z
  2. Nielsen, K. L. et al. Fitness cost: a bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic. J. Antimicrob. Chemother. 67, 1325–1332 (2012). · doi:10.1093/jac/dks051
  3. Rolain, J. M., Abat, C., Brouqui, P. & Raoult, D. Worldwide decrease in methicillin-resistant Staphylococcus aureus: do we understand something? Clin. Microbiol. Infect. 21, 515–517 (2015). · doi:10.1016/j.cmi.2015.04.017
  4. Mendes, R. E. et al. Regional resistance surveillance program results for 12 Asia-Pacific nations (2011). Antimicrob. Agents Chemother. 57, 5721–5726 (2013). · DOI
  5. Lucet, J. C. et al. Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members. Arch. Intern. Med. 169, 1372–1378 (2009). · doi:10.1001/archinternmed.2009.217
  6. Kim, C. et al. Properties of a novel PBP2A protein homolog from Staphylococcus aureus strain LGA251 and its contribution to the beta-lactam-resistant phenotype. J. Biol. Chem. 287, 36854–36863 (2012). · doi:10.1074/jbc.m112.395962
  7. Milheirico, C., de Lencastre, H. & Tomasz, A. Full-genome sequencing identifies in the genetic background several determinants that modulate the resistance phenotype in methicillin-resistant Staphylococcus aureus strains carrying the novel mecC gene. Antimicrob. Agents Chemother. 61, e02500–16 (2017). · doi:10.1128/aac.02500-16
  8. Kim, C. K., Milheirico, C., de Lencastre, H. & Tomasz, A. Antibiotic resistance as a stress response: recovery of high-level oxacillin resistance in methicillin-resistant Staphylococcus aureus “Auxiliary” (fem) mutants by induction of the stringent stress response. Antimicrob. Agents Chemother 61, e00313-17 (2017). · doi:10.1128/aac.00313-17
  9. Penn, C. et al. Wound infections caused by inducible meticillin-resistant Staphylococcus aureus strains. J. Glob. Antimicrob. Resist 1, 79–83 (2013). · doi:10.1016/j.jgar.2013.03.009
  10. Malhotra- Kumar, S. et al. Evaluation of molecular assays for rapid detection of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 48, 4598–4601 (2010). · doi:10.1128/jcm.00004-10
  11. Millar, E. V. et al. Genomic characterization of USA300 methicillin-resistant Staphylococcus aureus (MRSA) to evaluate intraclass transmission and recurrence of skin and soft tissue infection (SSTI) among high-risk military trainees. Clin. Infect. Dis. 65, 461–468 (2017). · doi:10.1093/cid/cix327
  12. Merlino, J., Leroi, M., Bradbury, R., Veal, D. & Harbour, C. New chromogenic identification and detection of Staphylococcus aureus and methicillin-resistant S. aureus. J. Clin. Microbiol. 38, 2378–2380 (2000). · doi:10.1128/jcm.38.6.2378-2380.2000
  13. Gazin, M. et al. Culture-based detection of methicillin-resistant Staphylococcus aureus by a network of European laboratories: an external quality assessment study. Eur. J. Clin. Microbiol. Infect. Dis. 31, 1765–1770 (2012). · doi:10.1007/s10096-011-1499-0
  14. Luthje, P. et al. Identification of microorganisms grown on chromogenic media by MALDI-TOF MS. J. Microbiol. Methods 136, 17–20 (2017). · doi:10.1016/j.mimet.2017.03.001
  15. Cunningham, R. et al. Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J. Hosp. Infect. 65, 24–28 (2007). · doi:10.1016/j.jhin.2006.09.019
  16. Wu, P. J., Jeyaratnam, D., Tosas, O., Cooper, B. S. & French, G. L. Point-of-care universal screening for meticillin-resistant Staphylococcus aureus: a cluster-randomized cross-over trial. J. Hosp. Infect. 95, 245–252 (2017). · doi:10.1016/j.jhin.2016.08.017
  17. World Health Organization. WHO Guidelines on Hand Hygiene in Health Care. World Alliance for Patient Safety (WHO Press, Geneva, 2009).
  18. Robotham, J. V. et al. Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study. Lancet Infect. Dis. 16, 348–356 (2016). · doi:10.1016/s1473-3099(15)00417-x
  19. Derde, L. P. et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect. Dis. 14, 31–39 (2014). · DOI · Paper page
  20. Fatkenheuer, G., Hirschel, B. & Harbarth, S. Screening and isolation to control meticillin-resistant Staphylococcus aureus: sense, nonsense, and evidence. Lancet 385, 1146–1149 (2015). This commentary provides an update regarding the growing evidence for and against the role of active surveillance in MRSA control. · DOI
  21. Ammerlaan, H. S. et al. Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure. J. Antimicrob. Chemother. 66, 2418–2424 (2011). · doi:10.1093/jac/dkr250
  22. Houlihan, H. H., Mercier, R. C. & Rybak, M. J. Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model. Antimicrob. Agents Chemother. 41, 2497–2501 (1997). · doi:10.1128/aac.41.11.2497
  23. Andrey, D. O. et al. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013–2014 at the Geneva University Hospitals. Eur. J. Clin. Microbiol. Infect. Dis. 36, 343–350 (2017). · doi:10.1007/s10096-016-2807-5
  24. Mendes, R. E. et al. Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline. J. Antimicrob. Chemother. 67, 1321–1324 (2012). · doi:10.1093/jac/dks069
  25. De Angelis, G., Murthy, A., Beyersmann, J. & Harbarth, S. Estimating the impact of healthcare-associated infections on length of stay and costs. Clin. Microbiol. Infect. 16, 1729–1735 (2010). · doi:10.1111/j.1469-0691.2010.03332.x
  26. Haessler, S., Mackenzie, T. & Kirkland, K. B. Long-term outcomes following infection with meticillin-resistant or meticillin-susceptible Staphylococcus aureus. J. Hosp. Infect. 69, 39–45 (2008). · doi:10.1016/j.jhin.2008.01.008
  27. Herr, C. E., Heckrodt, T. H., Hofmann, F. A., Schnettler, R. & Eikmann, T. F. Additional costs for preventing the spread of methicillin-resistant Staphylococcus aureus and a strategy for reducing these costs on a surgical ward. Infect. Control Hosp. Epidemiol. 24, 673–678 (2003). · doi:10.1086/502274
  28. Bekeredjian-Ding, I. Deciphering the significance of the T cell response to Staphylococcus aureus. Future Microbiol. 12, 1023–1026 (2017). · doi:10.2217/fmb-2017-0138
  29. Pea, F. et al. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. J. Antimicrob. Chemother. 67, 2034–2042 (2012). · doi:10.1093/jac/dks153
  30. Dryden, M., Zhang, Y., Wilson, D., Iaconis, J. P. & Gonzalez, J. A. Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities. J. Antimicrob. Chemother. 71, 3575–3584 (2016). · doi:10.1093/jac/dkw333
  31. Van Bambeke, F. Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy. Future Microbiol. 10, 1111–1123 (2015). · doi:10.2217/fmb.15.39

Cited by

See all 1,556

Metadata

Authors
Lee, A. S., de Lencastre, H., Garau, J., Kluytmans, J., Malhotra-Kumar, S., Peschel, A., & Harbarth, S.
Venue
Nature Reviews Disease Primers
Published
2018-05-31
Volume
4
Issue
1
Pages
18033-18033
ISSN
2056-676X (ISSN-L)
OpenAlex
W2312720395
Cited by
1,556
References
220
FWCI
15.12
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.